Skip to main content

Table 2 Procedural characteristics at the time of tracheostomy

From: Severe pain-related adverse events of percutaneous dilatational tracheostomy performed by a neurointensivist compared with conventional surgical tracheostomy in neurocritically ill patients

 

PDT performed by a neurointensivist (n = 71)

Conventional surgical method (n = 85)

P value

Reason for tracheostomy — No. of patients (%)

  

0.853

 Difficult ventilator weaning or prolonged intubation

33 (46.5)

34 (40.0)

 

 Reduction of sedative

15 (21.1)

22 (25.9)

 

 Airway protection or prevent the risk of aspiration

15 (21.1)

21 (24.7)

 

 Airway toilet

5 (7.0)

4 (4.7)

 

 Difficult airway

3 (4.2)

4 (4.7)

 

Premedication — No. of patients (%)

 Midazolam

44 (62.0)

65 (76.5)

0.049

 Cisatracurium

59 (83.1)

2 (2.4)

< 0.001

 Fentanyl

55 (77.5)

2 (2.4)

< 0.001

 Pethidine

15 (21.1)

29 (34.1)

0.106

 Propofol

15 (21.1)

2 (2.4)

0.001

 Vecuronium

11 (15.5)

2 (2.4)

0.008

 Remifentanil

7 (9.9)

4 (4.7)

0.348

 Succinylcholine

3 (4.2)

16 (18.8)

0.011

 Other

5 (7.0)

8 (9.4)

0.808

Anticoagulation — No. of patients (%)

0 (0.0)

1 (1.2)

0.999

Use of antiplatelet agent — No. of patients (%)

5 (7.0)

1 (1.2)

0.093

GCS on procedure — mean ± SD

8.6 ± 3.7

8.3 ± 3.5

0.653

Use of renal replacement therapy — No. of patients (%)

3 (4.2)

3 (3.5)

0.999

Invasive ICP monitoring — No. of patients (%)

20 (28.2)

25 (29.4)

0.865

Duration of mechanical ventilation before tracheostomy (days) — mean ± SD

8.9 ± 5.8

8.2 ± 5.8

0.406

Inserted site — No. of patients (%)

  

0.045

 1st tracheal membrane

16 (22.5)

35 (41.2)

 

 2nd tracheal membrane

39 (54.9)

34 (40.0)

 

 3rd tracheal membrane

16 (22.5)

16 (18.8)

 

Internal diameter of T-cannula (mm) — No. of patients (%)

  

< 0.001

 6.0

0 (0)

1 (1.2)

 

 7.0

1 (1.4)

22 (25.9)

 

 7.5

35 (49.3)

35 (41.2)

 

 8.0

33 (46.5)

24 (28.2)

 

 Adjustable flange

2 (2.8)

3 (3.5)

 

Lab results on the day of tracheostomy — mean ± SD

 Platelet count (× 103/μl)

252.2 ± 111.6

266.1 ± 107.0

0.440

 PT (INR)

1.0 ± 0.2

1.0 ± 0.1

0.461

 aPTT (sec)

38.9 ± 9.5

37.6 ± 6.4

0.330

Ventilator setting — mean ± SD

 FiO2 (%)

39.9 ± 18.6

36.0 ± 7.0

0.094

 PEEP (cmH2O)

5.1 ± 0.8

4.9 ± 1.8

0.315

Vasopressor requirement — No. of patients (%)

11 (15.5)

13 (15.3)

0.973

  1. PDT Percutaneous dilatational tracheostomy, SD standard deviation, ICP intracranial pressure, INR international normalized ratio, aPTT activated partial thromboplastin time, FiO2 Fraction of inspired oxygen, PEEP positive end-expiratory pressure